Terry Dagnon - Apr 17, 2023 Form 4 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Signature
/s/ Lawrence Kenyon, Attorney-in-Fact
Stock symbol
OTLK
Transactions as of
Apr 17, 2023
Transactions value $
$0
Form type
4
Date filed
4/19/2023, 05:41 PM
Previous filing
Jun 23, 2022
Next filing
Apr 21, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option shall vest on April 17, 2024, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. The option is also subject to acceleration under certain circumstances.